Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 16.50
+0.06 (0.36%)
At close: Apr 13, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 780.9 million as of April 14, 2026. Its market cap has increased by 44.26% in one year.
Market Cap
780.90M
Enterprise Value
301.55M
Revenue
57.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.50
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 780.90M, a decrease of -48.54%. That is a compound annual growth rate of -30.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 767.87M | -14.33% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.14B |
| Cereno Scientific AB | 2.01B |
| EQL Pharma AB | 1.64B |
| Dicot Pharma AB | 791.28M |
| Orexo AB | 731.61M |
| Enzymatica AB | 730.63M |
| Nanexa AB | 641.88M |
| Moberg Pharma AB | 473.77M |